Fig. 18.1 Robotic stereotactic body radiotherapy unit (Courtesy of Hacettepe University) We do not recommend rSBRT in patients with collagen vascular disease and inflammatory bowel disease. We can treat patients…
Fig. 25.1 Ga-68 PSMA PET/CT revealed a left parailiac lymph node (LN) of 16 × 19 mm (SUVmax: 5.85) Fig. 25.2 SBRT Plan of Case 1: 35 Gy (7 Gy/day in 5 fractions)…
Fig. 19.1 Dose deposition characteristics of protons vs. X-rays Because of the absence of an exit dose, proton therapy can be used to treat cancer patients with less scatter radiation…
Author (year) n RT course RT dose (Gy) OS CSS CR (%) Salvage RC (%) aHousset et al. (1993) 54 Split course 44 (bid) 3y, 59% 3y, 62% 74 –…
Fig. 9.1 Bilateral retroperitoneal metastasis of left testicular tumor, medializing aorta and vena cava Post-chemo residual masses are teratomas in 40% of NSGCT cases [11]. In a study including 210…
Fig. 3.1 CTV delineation for a muscle-invasive bladder cancer patient treated with definitive IGRT Fig. 3.2 Boost volume delineation for a muscle-invasive bladder cancer patient treated with definitive IGRT 3.4.3…
AJCC 7th Edition (2009) Note: new staging incorporates Gleason + PSA for risk group determination Primary tumor: T1—clinically inapparent tumor neither palpable nor visible by imaging T1a—incidental histologic finding in…
LN levels Boundaries of LN levels Recommended margins Superior Inferior Medial Lateral Anterior Posterior Internal iliac Bifurcation of the CI (usually the L5–S1 interspace) Superior portion of the coccygeal muscle…
© Springer International Publishing AG 2017Gokhan Ozyigit and Ugur Selek (eds.)Principles and Practice of Urooncologyhttps://doi.org/10.1007/978-3-319-56114-1_26 26. Quality Assurance of Modern Radiotherapy Techniques in Prostate Cancer Treatment Vildan Alpan1 , Yücel Sağlam1 and Steven Kirsner2 (1) Department of Radiation Oncology,…
Androgen inhibitors Abiraterone FDA approval For metastatic CRPC before chemotherapy For metastatic CRPC following docetaxel Orteronel (TAK-700) Phase III Maintenance therapy in patients with mCRPC previously treated with novel hormonal…
